Browsing by Author Coyle, Luke

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2015Axonal excitability in primary amyloidotic neuropathyBurke, David; Ng, Karl; Coyle, Luke; Ghaoui, Roula; Hafner, Jessica; Central Clinical School: Medicine; Central Clinical School: MedicineAxonal excitability in primary amyloidotic neuropathy, Muscle and Nerve, vol.51, 3, 2015,pp 443-445
2006Elevated serum FGF23 concentrations in plasma cell dyscrasiasClifton-Bligh, Phillip; Clifton-Bligh, Roderick; Coyle, Luke; Mason, Rebecca; Mirams, Michiko; Robinson, Bruce; Stewart, Inge; Ward, Christopher; Clarkson, Adele; Gill, Anthony; Roddie, Claire; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; School of Medical Sciences: Physiology; School of Medical Sciences: Physiology; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Medicine Faculty OfficeElevated serum FGF23 concentrations in plasma cell dyscrasias, Bone, vol.39,(2),2006,pp 369-376
2013Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological diseaseCoyle, Luke; Jones, Brett; Pattullo, Venessa; Chen, Fei; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Western Clinical School: Medicine (Westmead)Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease, Liver International, vol.33, 8, 2013,pp 1203-1210
2006The laboratory diagnosis of lupus anticoagulant in patients on oral anticoagulation.Coyle, Luke; Ward, Christopher; Aboud, M.; Roddie, C; Northern Clinical School: Medicine; Medicine Faculty OfficeThe laboratory diagnosis of lupus anticoagulant in patients on oral anticoagulation., Clinical and Laboratory Haematology, vol.28,(2),2006,pp 105-110
2003Recombinant activated factor VII for the treatment of life-threatening haemorrhageCoyle, Luke; Eikelboom, John; Ward, Christopher; Bird, R; Blythe, D; et, al; Gan, E; Harvey, M; Isbister, J; Leahy, M; McIlroy, D; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Medicine Faculty OfficeRecombinant activated factor VII for the treatment of life-threatening haemorrhage, Blood Coagulation & Fibrinolysis, vol.14,(8),2003,pp 713-717
2017Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantationGreenwood, Matthew; Kerridge, Ian; Stevenson, William; Arthur, Christopher; Coyle, Luke; Fay, Keith; Lindsay, Julian; Sandaradura, Indy; Wong, Kelly; Northern Clinical School: Kolling Institute; School of Public Health: Ctr for Values Ethics & Law in Med; Northern Clinical School: MedicineSerum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation, Journal of Antimicrobial Chemotherapy, vol.72, 12, 2017,pp 3414-3419
2007Use of a functional assay to diagnose protein S deficiency; inappropriate testing yields equivocal resultsAboud, M; Coyle, Luke; Johnstone, A; Morel-Kopp, Marie-Christine; Ward, Christopher; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: MedicineUse of a functional assay to diagnose protein S deficiency; inappropriate testing yields equivocal results, Internal Medicine Journal, vol.37,(6),2007,pp 409-411